PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
39.96
+6.87 (20.74%)
May 20, 2024, 10:28 AM EDT - Market open
PTC Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for PTC Therapeutics stock have an average target of 31.25, with a low estimate of 17 and a high estimate of 50. The average target predicts a decrease of -21.80% from the current stock price of 39.96.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for PTCT stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 6 | 6 | 6 | 5 | 6 | 6 |
| Sell | 3 | 3 | 3 | 3 | 2 | 2 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 14 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $28 → $30 | Sell → Hold | Upgrades | $28 → $30 | -24.92% | Apr 29, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +12.61% | Apr 12, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $33 → $35 | Strong Buy | Maintains | $33 → $35 | -12.41% | Mar 20, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $28 | Hold | Reiterates | $28 | -29.93% | Mar 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $28 | Hold | Maintains | $22 → $28 | -29.93% | Mar 1, 2024 |
Financial Forecast
Revenue This Year
619.31M
from 937.82M
Decreased by -33.96%
Revenue Next Year
636.39M
from 619.31M
Increased by 2.76%
EPS This Year
-6.00
from -8.37
EPS Next Year
-5.07
from -6.00
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 709.6M | 795.2M | 1.2B | 1.3B | 1.6B |
| Avg | 619.3M | 636.4M | 778.6M | 836.4M | 1.1B |
| Low | 460.3M | 326.1M | 362.1M | 457.2M | 518.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -24.3% | 28.4% | 93.1% | 72.6% | 92.5% |
| Avg | -34.0% | 2.8% | 22.3% | 7.4% | 25.7% |
| Low | -50.9% | -47.3% | -43.1% | -41.3% | -38.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.79 | -2.05 | 2.60 | -3.56 | -0.53 |
| Avg | -6.00 | -5.07 | -2.48 | -3.52 | -1.26 |
| Low | -8.28 | -8.98 | -6.17 | -3.44 | -1.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.